Revisiting luteolin: An updated review on its anticancer potential
- PMID: 38455556
- PMCID: PMC10918152
- DOI: 10.1016/j.heliyon.2024.e26701
Revisiting luteolin: An updated review on its anticancer potential
Abstract
Numerous natural products found in our diet, such as polyphenols and flavonoids, can prevent the progression of cancer. Luteolin, a natural flavone, present in significant amounts in various fruits and vegetables plays a key role as a chemopreventive agent in treating various types of cancer. By inducing apoptosis, initiating cell cycle arrest, and decreasing angiogenesis, metastasis, and cell proliferation, luteolin is used to treat cancer. Its anticancer properties are attributed to its capability to engage with multiple molecular targeted sites and modify various signaling pathways in tumor cells. Luteolin has been shown to slow the spread of cancer in breast, colorectal, lung, prostate, liver, skin, pancreatic, oral, and gastric cancer models. It exhibits antioxidant properties and can be given to patients receiving Doxorubicin (DOX) chemotherapy to prevent the development of unexpected adverse reactions in the lungs and hematopoietic system subjected to DOX. Furthermore, it could be an excellent candidate for synergistic studies to overcome drug resistance in cancer cells. Accordingly, this review covers the recent literature related to the use of luteolin against different types of cancer, along with the mechanisms of action. In addition, the review highlights luteolin as a complementary medicine for preventing and treating cancer.
Keywords: Anticancer; Luteolin; Metastasis; Phytochemical.
© 2024 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:No competing interests If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Luteolin, a flavonoid, as an anticancer agent: A review.Biomed Pharmacother. 2019 Apr;112:108612. doi: 10.1016/j.biopha.2019.108612. Epub 2019 Feb 21. Biomed Pharmacother. 2019. PMID: 30798142 Review.
-
Therapeutic Potential of Luteolin on Cancer.Vaccines (Basel). 2023 Feb 27;11(3):554. doi: 10.3390/vaccines11030554. Vaccines (Basel). 2023. PMID: 36992138 Free PMC article. Review.
-
Progress, pharmacokinetics and future perspectives of luteolin modulating signaling pathways to exert anticancer effects: A review.Medicine (Baltimore). 2024 Aug 23;103(34):e39398. doi: 10.1097/MD.0000000000039398. Medicine (Baltimore). 2024. PMID: 39183411 Free PMC article. Review.
-
Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated.Phytother Res. 2021 Jul;35(7):3509-3532. doi: 10.1002/ptr.7044. Epub 2021 Feb 13. Phytother Res. 2021. PMID: 33580629 Review.
-
Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives.Cancers (Basel). 2022 Oct 31;14(21):5373. doi: 10.3390/cancers14215373. Cancers (Basel). 2022. PMID: 36358791 Free PMC article. Review.
Cited by
-
Inhibition of hepatic stellate cell activation by nutraceuticals: an emphasis on mechanisms of action.J Food Sci Technol. 2024 Nov;61(11):2046-2056. doi: 10.1007/s13197-024-06002-3. Epub 2024 May 18. J Food Sci Technol. 2024. PMID: 39397845 Review.
-
Natural polyphenols: A protective approach to reduce colorectal cancer.Heliyon. 2024 Jun 6;10(11):e32390. doi: 10.1016/j.heliyon.2024.e32390. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38961927 Free PMC article. Review.
-
Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: a comprehensive review.Inflammopharmacology. 2025 Jan;33(1):145-162. doi: 10.1007/s10787-024-01635-4. Epub 2025 Jan 7. Inflammopharmacology. 2025. PMID: 39776026 Review.
-
Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer.Int J Mol Sci. 2025 Jan 13;26(2):631. doi: 10.3390/ijms26020631. Int J Mol Sci. 2025. PMID: 39859345 Free PMC article. Review.
-
A Comprehensive Review of the Phytochemical Constituents and Bioactivities of Ocimum tenuiflorum.ScientificWorldJournal. 2024 Oct 22;2024:8895039. doi: 10.1155/2024/8895039. eCollection 2024. ScientificWorldJournal. 2024. PMID: 39473808 Free PMC article. Review.
References
-
- WHO, World Health Organization Cancer. 2022 https://www.who.int/news-room/fact-sheets/detail/cancer
Publication types
LinkOut - more resources
Full Text Sources